nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Actin is where it's at
|
Lindberg, Uno |
|
2008 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
2 |
Adjuvant histamine in cancer immunotherapy
|
Hellstrand, Kristoffer |
|
2000 |
40-41 |
1 |
p. 29-39 11 p. |
artikel |
3 |
Androgen-regulated gene expression in prostate cancer
|
Trapman, Jan |
|
1997 |
40-41 |
1 |
p. 29-36 8 p. |
artikel |
4 |
Aneuploidy and genetic instability in cancer
|
Lengauer, Christoph |
|
2005 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
5 |
An overview of renal cell cancer: Pathology and genetics
|
Moch, Holger |
|
2013 |
40-41 |
1 |
p. 3-9 7 p. |
artikel |
6 |
Association of SV40 with human tumours
|
Jasani, B. |
|
2001 |
40-41 |
1 |
p. 49-61 13 p. |
artikel |
7 |
Assumptions of the tumor ‘escape’ hypothesis
|
Restifo, Nicholas P |
|
2002 |
40-41 |
1 |
p. 81-86 6 p. |
artikel |
8 |
Basic science aspects of prostate cancer
|
Dorkin, Trevor J. |
|
1997 |
40-41 |
1 |
p. 21-27 7 p. |
artikel |
9 |
Bcl-2 family proteins as regulators of oxidative stress
|
Susnow, Nathan |
|
2009 |
40-41 |
1 |
p. 42-49 8 p. |
artikel |
10 |
Bench to bedside and back again: Molecular mechanisms of α-catenin function and roles in tumorigenesis
|
Benjamin, Jacqueline M. |
|
2008 |
40-41 |
1 |
p. 53-64 12 p. |
artikel |
11 |
Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the bad
|
Nejak-Bowen, Kari Nichole |
|
2011 |
40-41 |
1 |
p. 44-58 15 p. |
artikel |
12 |
Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine
|
Molnár, Eszter Lázár |
|
2000 |
40-41 |
1 |
p. 25-28 4 p. |
artikel |
13 |
Cancer immunotherapy: Are we there yet?
|
Sredni, Benjamin |
|
2012 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
14 |
Cancer-related inflammation: Common themes and therapeutic opportunities
|
Balkwill, Frances R. |
|
2012 |
40-41 |
1 |
p. 33-40 8 p. |
artikel |
15 |
Can chromosomal instability initiate tumorigenesis?
|
Michor, Franziska |
|
2005 |
40-41 |
1 |
p. 43-49 7 p. |
artikel |
16 |
Can mouse models for brain tumors inform treatment in pediatric patients?
|
Weiss, William A |
|
2004 |
40-41 |
1 |
p. 71-77 7 p. |
artikel |
17 |
Cell death in health and disease: the biology and regulation of apoptosis
|
Bellamy, Christopher O.C. |
|
1995 |
40-41 |
1 |
p. 3-16 14 p. |
artikel |
18 |
Cell–matrix adhesion complexes: Master control machinery of cell migration
|
Lock, John G. |
|
2008 |
40-41 |
1 |
p. 65-76 12 p. |
artikel |
19 |
Cellular transformation by SV40 large T antigen: interaction with host proteins
|
Ali, Syed Hamid |
|
2001 |
40-41 |
1 |
p. 15-22 8 p. |
artikel |
20 |
Centrosomal amplification and spindle multipolarity in cancer cells
|
Saunders, William |
|
2005 |
40-41 |
1 |
p. 25-32 8 p. |
artikel |
21 |
Chronic inflammation, immunosuppression and cancer: New insights and outlook
|
Baniyash, Michal |
|
2006 |
40-41 |
1 |
p. 80-88 9 p. |
artikel |
22 |
Clinical applications of genetic rearrangements in cancer
|
Sheer, Denise |
|
1996 |
40-41 |
1 |
p. 25-32 8 p. |
artikel |
23 |
Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer
|
Giuriato, Sylvie |
|
2004 |
40-41 |
1 |
p. 3-11 9 p. |
artikel |
24 |
Connecting mitotic instability and chromosome aberrations in cancer—can telomeres bridge the gap?
|
Gisselsson, David |
|
2005 |
40-41 |
1 |
p. 13-23 11 p. |
artikel |
25 |
Current and future systemic treatments for renal cell carcinoma
|
Fisher, Rosalie |
|
2013 |
40-41 |
1 |
p. 38-45 8 p. |
artikel |
26 |
Defective death receptor signaling as a cause of tumor immune escape
|
French, Lars E |
|
2002 |
40-41 |
1 |
p. 51-55 5 p. |
artikel |
27 |
Deregulated degradation of the cdk inhibitor p27 and malignant transformation
|
Bloom, Joanna |
|
2003 |
40-41 |
1 |
p. 41-47 7 p. |
artikel |
28 |
Drug discovery in the p53 field
|
Lain, Sonia |
|
2010 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
29 |
Editorial Advisory Board
|
Klein, Eva |
|
2003 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
30 |
Editorial Board
|
|
|
2008 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
31 |
Editorial Board
|
|
|
2010 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
32 |
Editorial Board
|
|
|
2009 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
33 |
Editorial Board
|
|
|
2013 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
34 |
Editorial Board
|
|
|
2011 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
35 |
Editorial Board
|
|
|
2012 |
40-41 |
1 |
p. CO2- 1 p. |
artikel |
36 |
Erratum to “BRCA1 methylation: a significant role in tumour development?” [Seminars in Cancer Biology 12 (2002) 359–371]
|
Catteau, A. |
|
2003 |
40-41 |
1 |
p. 91- 1 p. |
artikel |
37 |
Escape from immune- and nonimmune-mediated tumor surveillance
|
Malmberg, Karl-Johan |
|
2006 |
40-41 |
1 |
p. 16-31 16 p. |
artikel |
38 |
Family studies and the evidence for genetic susceptibility to prostate cancer
|
Bishop, D.Timothy |
|
1997 |
40-41 |
1 |
p. 45-51 7 p. |
artikel |
39 |
Focal adhesion kinase as a regulator of cell tension in the progression of cancer
|
Tilghman, Robert W. |
|
2008 |
40-41 |
1 |
p. 45-52 8 p. |
artikel |
40 |
Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis
|
Kuttler, Fabien |
|
2007 |
40-41 |
1 |
p. 56-64 9 p. |
artikel |
41 |
Gene fusions encoding chimaeric transcription factors in solid tumours
|
Sorensen, Poul H.B. |
|
1996 |
40-41 |
1 |
p. 3-14 12 p. |
artikel |
42 |
Gene signatures in hepatocellular carcinoma (HCC)
|
Andrisani, Ourania M. |
|
2011 |
40-41 |
1 |
p. 4-9 6 p. |
artikel |
43 |
Gene therapy for prostate cancer
|
Bower, Mark |
|
1997 |
40-41 |
1 |
p. 3-9 7 p. |
artikel |
44 |
Genetically modulating T-cell function to target cancer
|
Merhavi-Shoham, Efrat |
|
2012 |
40-41 |
1 |
p. 14-22 9 p. |
artikel |
45 |
Genetic predisposition to cancer—issues to consider
|
Malkin, David |
|
1996 |
40-41 |
1 |
p. 49-53 5 p. |
artikel |
46 |
Genomic imprinting in tumours
|
Squire, Jeremy |
|
1996 |
40-41 |
1 |
p. 41-47 7 p. |
artikel |
47 |
Genomic mechanisms and measurement of structural and numerical instability in cancer cells
|
Bayani, Jane |
|
2007 |
40-41 |
1 |
p. 5-18 14 p. |
artikel |
48 |
Genomics and epigenomics of renal cell carcinoma
|
Maher, Eamonn R. |
|
2013 |
40-41 |
1 |
p. 10-17 8 p. |
artikel |
49 |
Genomic stability and tumorigenesis
|
Sieber, Oliver |
|
2005 |
40-41 |
1 |
p. 61-66 6 p. |
artikel |
50 |
H2-antagonists in the treatment of colon and breast cancer
|
Bolton, Elaine |
|
2000 |
40-41 |
1 |
p. 3-10 8 p. |
artikel |
51 |
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy
|
Mathupala, Saroj P. |
|
2009 |
40-41 |
1 |
p. 17-24 8 p. |
artikel |
52 |
H1 histamine receptor antagonist inhibits constitutive growth of Jurkat T cells and antigen-specific proliferation of ovalbumin-specific murine T cells
|
Radvány, Zsuzsa |
|
2000 |
40-41 |
1 |
p. 41-45 5 p. |
artikel |
53 |
Histamine as an autocrine growth factor: an unusual role for a widespread mediator
|
Rivera, Elena S. |
|
2000 |
40-41 |
1 |
p. 15-23 9 p. |
artikel |
54 |
Histamine in brain development and tumors
|
Panula, Pertti |
|
2000 |
40-41 |
1 |
p. 11-14 4 p. |
artikel |
55 |
HLA class I antigen abnormalities and immune escape by malignant cells
|
Seliger, Barbara |
|
2002 |
40-41 |
1 |
p. 3-13 11 p. |
artikel |
56 |
HLA-G and HLA-C at the feto–maternal interface: lessons learned from pathogenic viruses
|
Schust, Danny J. |
|
1999 |
40-41 |
1 |
p. 37-46 10 p. |
artikel |
57 |
HLA-G: a new opening for HLA
|
Dausset, J. |
|
1999 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
58 |
HLA-G expression: immune privilege for tumour cells?
|
Cabestre, Francisco Adrian |
|
1999 |
40-41 |
1 |
p. 27-36 10 p. |
artikel |
59 |
Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense
|
Olovnikov, Ivan A. |
|
2009 |
40-41 |
1 |
p. 32-41 10 p. |
artikel |
60 |
How do NK cells sense the expression of HLA-G class Ib molecules?
|
López-Botet, Miguel |
|
1999 |
40-41 |
1 |
p. 19-26 8 p. |
artikel |
61 |
Human papillomavirus-induced carcinogenesis and the ubiquitin–proteasome system
|
Scheffner, Martin |
|
2003 |
40-41 |
1 |
p. 59-67 9 p. |
artikel |
62 |
Immune suppression by tumor-specific CD4+ regulatory T-cells in cancer
|
Wang, Rong-Fu |
|
2006 |
40-41 |
1 |
p. 73-79 7 p. |
artikel |
63 |
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention
|
Whiteside, Theresa L. |
|
2006 |
40-41 |
1 |
p. 3-15 13 p. |
artikel |
64 |
Immunodominance and tumor escape
|
Schreiber, H. |
|
2002 |
40-41 |
1 |
p. 25-31 7 p. |
artikel |
65 |
Immunomodulating tellurium compounds as anti-cancer agents
|
Sredni, Benjamin |
|
2012 |
40-41 |
1 |
p. 60-69 10 p. |
artikel |
66 |
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy
|
Ruiz-Cabello, Francisco |
|
2002 |
40-41 |
1 |
p. 15-24 10 p. |
artikel |
67 |
Implications of apoptotic cell death regulation in cancer therapy
|
McDonnell, Timothy J. |
|
1995 |
40-41 |
1 |
p. 53-60 8 p. |
artikel |
68 |
Induction of apoptosis by tumor suppressor genes and oncogenes
|
Canman, Christine E. |
|
1995 |
40-41 |
1 |
p. 17-25 9 p. |
artikel |
69 |
Induction of genes during apoptosis: examples from the immune system
|
Osborne, Barbara A. |
|
1995 |
40-41 |
1 |
p. 27-33 7 p. |
artikel |
70 |
Inflammation and immune surveillance in cancer
|
Chow, Melvyn T. |
|
2012 |
40-41 |
1 |
p. 23-32 10 p. |
artikel |
71 |
Inflammation-associated immune suppression in cancer: The roles played by cytokines, chemokines and additional mediators
|
Ben-Baruch, A. |
|
2006 |
40-41 |
1 |
p. 38-52 15 p. |
artikel |
72 |
Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs
|
LaBella, Frank S. |
|
2000 |
40-41 |
1 |
p. 47-53 7 p. |
artikel |
73 |
Intracellular signaling and hepatocellular carcinoma
|
Iakova, Polina |
|
2011 |
40-41 |
1 |
p. 28-34 7 p. |
artikel |
74 |
Introduction
|
Ferrone, Soldano |
|
2002 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
75 |
Introduction
|
Carbone, Michele |
|
2001 |
40-41 |
1 |
p. 1-3 3 p. |
artikel |
76 |
Introduction and overview
|
Ciechanover, A. |
|
2003 |
40-41 |
1 |
p. 1-4 4 p. |
artikel |
77 |
Introduction: Apoptosis in oncogenesis and chemotherapy
|
Eastman, Alan |
|
1995 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
78 |
Introduction: Basic science aspects of prostate cancer
|
Waxman, Jonathan |
|
1997 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
79 |
Introduction: Genetic rearrangements in cancer
|
Sheer, Denise |
|
1996 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
80 |
Involvement of polyamines in apoptosis. Facts and controversies: effectors or protectors?
|
Schipper, Raymond G. |
|
2000 |
40-41 |
1 |
p. 55-68 14 p. |
artikel |
81 |
Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
|
Robey, R. Brooks |
|
2009 |
40-41 |
1 |
p. 25-31 7 p. |
artikel |
82 |
Kidney cancer
|
Johansson, Martin E. |
|
2013 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
83 |
Large common fragile site genes and cancer
|
Smith, David I. |
|
2007 |
40-41 |
1 |
p. 31-41 11 p. |
artikel |
84 |
Liver cancer epidemic in China: Past, present and future
|
Chen, Jian Guo |
|
2011 |
40-41 |
1 |
p. 59-69 11 p. |
artikel |
85 |
Mechanisms leading to chromosomal instability
|
Gollin, Susanne M. |
|
2005 |
40-41 |
1 |
p. 33-42 10 p. |
artikel |
86 |
Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia
|
Gollin, Susanne M. |
|
2007 |
40-41 |
1 |
p. 74-79 6 p. |
artikel |
87 |
MicroRNAs and genomic instability
|
Huppi, Konrad |
|
2007 |
40-41 |
1 |
p. 65-73 9 p. |
artikel |
88 |
MicroRNAs and STAT interplay
|
Kohanbash, Gary |
|
2012 |
40-41 |
1 |
p. 70-75 6 p. |
artikel |
89 |
Microsatellite instability and DNA mismatch repair in human cancer
|
Karran, Peter |
|
1996 |
40-41 |
1 |
p. 15-24 10 p. |
artikel |
90 |
Mitochondria as targets for cancer chemotherapy
|
Gogvadze, Vladimir |
|
2009 |
40-41 |
1 |
p. 57-66 10 p. |
artikel |
91 |
Mitochondria in cancer: Not just innocent bystanders
|
Frezza, Christian |
|
2009 |
40-41 |
1 |
p. 4-11 8 p. |
artikel |
92 |
Mitochondrial dynamics and cancer
|
Grandemange, Stéphanie |
|
2009 |
40-41 |
1 |
p. 50-56 7 p. |
artikel |
93 |
Mitogen-activated protein kinases in hepatocellular carcinoma development
|
Min, Lihua |
|
2011 |
40-41 |
1 |
p. 10-20 11 p. |
artikel |
94 |
Modeling non-random deletions in cancer
|
Kost-Alimova, Maria |
|
2007 |
40-41 |
1 |
p. 19-30 12 p. |
artikel |
95 |
Modulating the p53 pathway
|
Dey, Anwesha |
|
2010 |
40-41 |
1 |
p. 3-9 7 p. |
artikel |
96 |
Molecular signature of hepatocellular carcinoma, hope or hype in prognosis and therapy
|
Chen, Fei |
|
2011 |
40-41 |
1 |
p. 1-3 3 p. |
artikel |
97 |
Monoclonal antibodies for the treatment of cancer
|
Shuptrine, Casey W. |
|
2012 |
40-41 |
1 |
p. 3-13 11 p. |
artikel |
98 |
Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences?
|
Teixeira, Manuel R. |
|
2005 |
40-41 |
1 |
p. 3-12 10 p. |
artikel |
99 |
Mutations of the BRCA1 gene in human cancer
|
Xu, Chun-Fang |
|
1996 |
40-41 |
1 |
p. 33-40 8 p. |
artikel |
100 |
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
|
Serafini, Paolo |
|
2006 |
40-41 |
1 |
p. 53-65 13 p. |
artikel |
101 |
Natural killer cell-mediated recognition of human trophoblast
|
Biassoni, Roberto |
|
1999 |
40-41 |
1 |
p. 13-18 6 p. |
artikel |
102 |
Neoplastic “Black Ops”: Cancer's subversive tactics in overcoming host defenses
|
Biragyn, Arya |
|
2012 |
40-41 |
1 |
p. 50-59 10 p. |
artikel |
103 |
New approaches in identifying drugs to inactivate oncogene products
|
Liu, Ruiwu |
|
2004 |
40-41 |
1 |
p. 13-21 9 p. |
artikel |
104 |
NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
|
Amit, Sharon |
|
2003 |
40-41 |
1 |
p. 15-28 14 p. |
artikel |
105 |
Non-random genomic instability in cancer: A fact, not an illusion
|
Mai, Sabine |
|
2007 |
40-41 |
1 |
p. 1-4 4 p. |
artikel |
106 |
Oncogenes as therapeutic targets
|
Felsher, Dean W. |
|
2004 |
40-41 |
1 |
p. 1- 1 p. |
artikel |
107 |
p53 family members in cancer diagnosis and treatment
|
Machado-Silva, Alice |
|
2010 |
40-41 |
1 |
p. 57-62 6 p. |
artikel |
108 |
Prospects for an SV40 vaccine
|
Imperiale, Michael J |
|
2001 |
40-41 |
1 |
p. 81-85 5 p. |
artikel |
109 |
Prostate cancer; the interface between pathology and basic scientific research
|
Lalani, E.-N. |
|
1997 |
40-41 |
1 |
p. 53-59 7 p. |
artikel |
110 |
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
|
Semenza, Gregg L. |
|
2009 |
40-41 |
1 |
p. 12-16 5 p. |
artikel |
111 |
Regulation of the Fanconi anemia pathway by monoubiquitination
|
Gregory, Richard C. |
|
2003 |
40-41 |
1 |
p. 77-82 6 p. |
artikel |
112 |
Renal stem cells and their implications for kidney cancer
|
Axelson, Håkan |
|
2013 |
40-41 |
1 |
p. 56-61 6 p. |
artikel |
113 |
Reorganisation of the dendritic actin network during cancer cell migration and invasion
|
Vignjevic, Danijela |
|
2008 |
40-41 |
1 |
p. 12-22 11 p. |
artikel |
114 |
RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer
|
Fang, Shengyun |
|
2003 |
40-41 |
1 |
p. 5-14 10 p. |
artikel |
115 |
Role of T antigen interactions with p53 in tumorigenesis
|
Pipas, James M |
|
2001 |
40-41 |
1 |
p. 23-30 8 p. |
artikel |
116 |
Simian virus 40 regulatory region structural diversity and the association of viral archetypal regulatory regions with human brain tumors
|
Lednicky, John A. |
|
2001 |
40-41 |
1 |
p. 39-47 9 p. |
artikel |
117 |
Small-molecule inhibitors of MDM2 as new anticancer therapeutics
|
Dickens, Michael P. |
|
2010 |
40-41 |
1 |
p. 10-18 9 p. |
artikel |
118 |
Spatial genome organization in the formation of chromosomal translocations
|
Meaburn, Karen J. |
|
2007 |
40-41 |
1 |
p. 80-90 11 p. |
artikel |
119 |
Specificity, selection and significance of gene amplifications in cancer
|
Myllykangas, Samuel |
|
2007 |
40-41 |
1 |
p. 42-55 14 p. |
artikel |
120 |
Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas
|
Schrump, David S |
|
2001 |
40-41 |
1 |
p. 73-80 8 p. |
artikel |
121 |
Strategies to overcome immune ignorance and tolerance
|
Perales, Miguel-Angel |
|
2002 |
40-41 |
1 |
p. 63-71 9 p. |
artikel |
122 |
Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis
|
Eastman, Alan |
|
1995 |
40-41 |
1 |
p. 45-52 8 p. |
artikel |
123 |
SV40 and cell cycle perturbations in malignant mesothelioma
|
Testa, Joseph R. |
|
2001 |
40-41 |
1 |
p. 31-38 8 p. |
artikel |
124 |
SV40 and the pathogenesis of mesothelioma
|
Rizzo, Paola |
|
2001 |
40-41 |
1 |
p. 63-71 9 p. |
artikel |
125 |
Targeted therapies in myeloid leukemia
|
John, Alison M |
|
2004 |
40-41 |
1 |
p. 41-62 22 p. |
artikel |
126 |
Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate
|
Coutré, Steven |
|
2004 |
40-41 |
1 |
p. 23-31 9 p. |
artikel |
127 |
Targeting stroma to treat cancers
|
Engels, Boris |
|
2012 |
40-41 |
1 |
p. 41-49 9 p. |
artikel |
128 |
‘Targeting’ the epidermal growth factor receptor tyrosine kinase with gefitinib (Iressa®) in non-small cell lung cancer (NSCLC)
|
Pao, William |
|
2004 |
40-41 |
1 |
p. 33-40 8 p. |
artikel |
129 |
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
|
Allende-Vega, Nerea |
|
2010 |
40-41 |
1 |
p. 29-39 11 p. |
artikel |
130 |
Targets for molecular therapy of skin cancer
|
Green, Cheryl L |
|
2004 |
40-41 |
1 |
p. 63-69 7 p. |
artikel |
131 |
T cell dysfunction in cancer: Role of myeloid cells and tumor cells regulating amino acid availability and oxidative stress
|
Rodríguez, Paulo C. |
|
2006 |
40-41 |
1 |
p. 66-72 7 p. |
artikel |
132 |
The BCL-2 gene family
|
Craig, Ruth W. |
|
1995 |
40-41 |
1 |
p. 35-43 9 p. |
artikel |
133 |
The current clinical value of genomic instability
|
Diaz Jr., Luis A. |
|
2005 |
40-41 |
1 |
p. 67-71 5 p. |
artikel |
134 |
The discovery of nongenotoxic activators of p53: Building on a cell-based high-throughput screen
|
McCarthy, Anna R. |
|
2010 |
40-41 |
1 |
p. 40-45 6 p. |
artikel |
135 |
The evolutionary origin of genetic instability in cancer development
|
Breivik, Jarle |
|
2005 |
40-41 |
1 |
p. 51-60 10 p. |
artikel |
136 |
The genetic analysis of prostate carcinoma
|
Roylance, Rebecca |
|
1997 |
40-41 |
1 |
p. 37-44 8 p. |
artikel |
137 |
The immunotolerance role of HLA-G
|
Rouas-Freiss, Nathalie |
|
1999 |
40-41 |
1 |
p. 3-12 10 p. |
artikel |
138 |
The inflammation-cancer linkage: A double-edged sword?
|
Baniyash, Michal |
|
2006 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
139 |
The metabolic basis of kidney cancer
|
Linehan, W. Marston |
|
2013 |
40-41 |
1 |
p. 46-55 10 p. |
artikel |
140 |
The microfilament system and malignancy
|
Lindberg, Uno |
|
2008 |
40-41 |
1 |
p. 2-11 10 p. |
artikel |
141 |
The microfilament system in the formation of invasive adhesions
|
Gimona, Mario |
|
2008 |
40-41 |
1 |
p. 23-34 12 p. |
artikel |
142 |
The p53–Mdm2 module and the ubiquitin system
|
Michael, Dan |
|
2003 |
40-41 |
1 |
p. 49-58 10 p. |
artikel |
143 |
Therapeutic targeting of p53 by small molecules
|
Selivanova, Galina |
|
2010 |
40-41 |
1 |
p. 46-56 11 p. |
artikel |
144 |
The regulation of HLA class I expression: is HLA-G the odd one out?
|
Gobin, Sam J.P. |
|
1999 |
40-41 |
1 |
p. 55-59 5 p. |
artikel |
145 |
The regulation of MDM2 by multisite phosphorylation—Opportunities for molecular-based intervention to target tumours?
|
Meek, David W. |
|
2010 |
40-41 |
1 |
p. 19-28 10 p. |
artikel |
146 |
The role of peptide presentation in the physiological function of HLA-G
|
Münz, Christian |
|
1999 |
40-41 |
1 |
p. 47-54 8 p. |
artikel |
147 |
The role of the SV40 ST antigen in cell growth promotion and transformation
|
Rundell, Kathleen |
|
2001 |
40-41 |
1 |
p. 5-13 9 p. |
artikel |
148 |
The role of ubiquitylation in signaling by growth factors: implications to cancer
|
Shtiegman, Keren |
|
2003 |
40-41 |
1 |
p. 29-40 12 p. |
artikel |
149 |
The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets
|
Yang, Ju Dong |
|
2011 |
40-41 |
1 |
p. 35-43 9 p. |
artikel |
150 |
The ubiquitin/proteasome system in Epstein–Barr virus latency and associated malignancies
|
Dantuma, Nico P. |
|
2003 |
40-41 |
1 |
p. 69-76 8 p. |
artikel |
151 |
The VHL/HIF axis in clear cell renal carcinoma
|
Shen, Chuan |
|
2013 |
40-41 |
1 |
p. 18-25 8 p. |
artikel |
152 |
The von Hippel–Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis
|
Pugh, Christopher William |
|
2003 |
40-41 |
1 |
p. 83-89 7 p. |
artikel |
153 |
The Warburg Effect returns to the cancer stage
|
Zhivotovsky, Boris |
|
2009 |
40-41 |
1 |
p. 1-3 3 p. |
artikel |
154 |
Toll-like receptors, inflammation and cancer
|
Tsan, Min-Fu |
|
2006 |
40-41 |
1 |
p. 32-37 6 p. |
artikel |
155 |
Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton
|
O’Neill, G.M. |
|
2008 |
40-41 |
1 |
p. 35-44 10 p. |
artikel |
156 |
Tumor cell recognition by natural killer cells
|
Long, Eric O |
|
2002 |
40-41 |
1 |
p. 57-61 5 p. |
artikel |
157 |
Tumor immunology—towards a paradigm of reciprocal research
|
Drake, Charles G |
|
2002 |
40-41 |
1 |
p. 73-80 8 p. |
artikel |
158 |
Tumor-induced death of immune cells: its mechanisms and consequences
|
Whiteside, Theresa L |
|
2002 |
40-41 |
1 |
p. 43-50 8 p. |
artikel |
159 |
Tumour escape from immune surveillance through dendritic cell inactivation
|
Vicari, Alain P |
|
2002 |
40-41 |
1 |
p. 33-42 10 p. |
artikel |
160 |
Tumour suppressor genes in prostate cancer
|
MacGrogan, Donal |
|
1997 |
40-41 |
1 |
p. 11-19 9 p. |
artikel |
161 |
Von Hippel–Lindau: How a rare disease illuminates cancer biology
|
Richard, Stéphane |
|
2013 |
40-41 |
1 |
p. 26-37 12 p. |
artikel |
162 |
Yet unrevealed aspects of histamine: questions from outside–answers at inside?
|
László, Valéria |
|
2000 |
40-41 |
1 |
p. 1-2 2 p. |
artikel |
163 |
Zhx2 and Zbtb20: Novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer
|
Peterson, Martha L. |
|
2011 |
40-41 |
1 |
p. 21-27 7 p. |
artikel |